Inventors:
Thomas W. Hodge - Roswell GA, US
Natalie J. McDonald - Atlanta GA, US
Michael W. Shaw - Decatur GA, US
Donald H. Rubin - Nashville TN, US
Anthony Sanchez - Lilburn GA, US
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
Vanderbilt University - Nashville TN
International Classification:
C12Q 1/68, C12P 21/06
Abstract:
Host nucleic acids and host proteins that participate in viral infection, such as human immunodeficiency virus (HIV), influenza A, and Ebola virus, have been identified. Interfering with or disrupting the interaction between a host nucleic acid or host protein and a virus or viral protein confers an inhibition of or resistance to infection. Thus, interfering with such an interaction in a host subject can confer a therapeutic or prophylactic effect against a virus. The sequences identified can be used to identify agents that reduce or inhibit viral infection.